NDC 50242-175 – Evrysdi
Risdiplam .75 mg/mL · Powder, For Solution · Oral
Product NDC50242-175
Product details
- Brand name
- Evrysdi
- Generic name
- Risdiplam
- Labeler
- Genentech, Inc.
- Dosage form
- Powder, For Solution
- Route
- Oral
- Marketing category
- NDA · NDA213535
- Marketed since
- August 7, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Survival of Motor Neuron 2 Splicing Modifier
Active ingredients
- Risdiplam .75 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50242-175-07 | 1 BOTTLE, GLASS in 1 CARTON (50242-175-07) / 80 mL in 1 BOTTLE, GLASS | Aug 7, 2020 |
Recalls mentioning this NDC
- D-0357-2021 May 5, 2021 · Class III
Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with…
Other Evrysdi products
- 50242-202 Risdiplam 5 mg/1 · Tablet · Genentech, Inc.